Oak Street Health, Inc. (NYSE:OSH) COO Geoffrey M. Price sold 125,068 shares of the business’s stock in a transaction that occurred on Thursday, April 29th. The shares were sold at an average price of $61.72, for a total value of $7,719,196.96. Following the completion of the sale, the chief operating officer now owns 3,817,437 shares in the company, valued at approximately $235,612,211.64. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.
OSH opened at $61.07 on Tuesday. Oak Street Health, Inc. has a 52 week low of $37.11 and a 52 week high of $66.31. The business’s fifty day simple moving average is $58.43 and its 200 day simple moving average is $55.38.
Oak Street Health (NYSE:OSH) last posted its quarterly earnings results on Monday, March 8th. The company reported ($0.40) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.25) by ($0.15). The company had revenue of $248.70 million for the quarter, compared to the consensus estimate of $231.79 million. Oak Street Health’s revenue for the quarter was up 43.3% compared to the same quarter last year. As a group, sell-side analysts anticipate that Oak Street Health, Inc. will post -0.63 earnings per share for the current fiscal year.
OSH has been the subject of several analyst reports. Cantor Fitzgerald assumed coverage on shares of Oak Street Health in a research note on Monday, April 26th. They issued an “overweight” rating and a $75.00 target price for the company. Morgan Stanley raised their price target on shares of Oak Street Health from $73.00 to $79.00 and gave the stock an “overweight” rating in a research report on Thursday, March 18th. BTIG Research started coverage on Oak Street Health in a research note on Wednesday, January 6th. They set a “neutral” rating on the stock. Piper Sandler boosted their target price on shares of Oak Street Health from $59.00 to $69.00 in a research report on Wednesday, February 17th. Finally, Zacks Investment Research cut Oak Street Health from a “hold” rating to a “sell” rating in a report on Saturday, February 20th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and thirteen have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $67.54.
About Oak Street Health
Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2020, it operated 79 centers in Illinois, Indiana, Michigan, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas.
Recommended Story: How are Outstanding Shares Different from Authorized Shares?
Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.